Machine Learning–Based Biomarker Identification for Early Diagnosis of Metabolic Dysfunction–Associated Steatotic Liver Disease - Top-Institutions - MDSpire

Machine Learning–Based Biomarker Identification for Early Diagnosis of Metabolic Dysfunction–Associated Steatotic Liver Disease

  • By

  • Jolie Boullion

  • Amanda Husein

  • Akshat Agrawal

  • Diensn Xing

  • Md Ismail Hossain

  • Md Shenuarin Bhuiyan

  • Oren Rom

  • Steven A Conrad

  • John A Vanchiere

  • A Wayne Orr

  • Christopher G Kevil

  • Mohammad Alfrad Nobel Bhuiyan

  • February 21, 2025

  • 0 min

Share

Top Institutions in Endocrinology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Hepatology
    • Metabolic Diseases
    • Machine Learning in Medicine

  • #2

    University of California, San Diego (UCSD) - NAFLD Research Center
    University of California, San Diego (UCSD) - NAFLD Research Center

    San Diego, CA

    Key Differentiators

    • Hepatology
    • Metabolic Liver Disease
    • Biomedical Informatics

  • #3

    Mount Sinai Health System
    Mount Sinai Health System

    New York, NY

    Key Differentiators

    • Hepatology
    • Metabolic Syndrome
    • Clinical Informatics

  • #4

    University of Michigan Health System
    University of Michigan Health System

    Ann Arbor, MI

    Key Differentiators

    • Hepatology
    • Metabolic Disease Research
    • Data Science

  • #5

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Hepatology
    • Metabolic Liver Disease
    • Clinical Research

Original Source(s)

Machine Learning–Based Biomarker Identification for Early Diagnosis of Metabolic Dysfunction–Associated Steatotic Liver Disease

  • by Jolie Boullion, Amanda Husein, Akshat Agrawal, Diensn Xing, Md Ismail Hossain, Md Shenuarin Bhuiyan, Oren Rom, Steven A Conrad, John A Vanchiere, A Wayne Orr, Christopher G Kevil, Mohammad Alfrad Nobel Bhuiyan

  • February 21, 2025

Related Content

Lipid metabolism-MAFLD crosstalk: mechanisms and therapy

Schisandra chinensis Fructus and its active metabolites for the treatment of metabolic dysfunction-associated steatotic liver disease

Clinical validation of T1ρ mapping for the assessment of hepatic fibrosis in patients with chronic liver disease